Barclays

Barclays’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Barclays’s Portfolio PRVL Stock Details PRVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell
2020 Q4	$110K	Sell
2020 Q3	$322K	Buy
2020 Q2	$255K	Buy
2020 Q1	$121K	Buy
2019 Q4	$119K	Buy
2019 Q3	$47K	Buy